132 related articles for article (PubMed ID: 35945111)
21. Incidence, predictive factors and survival outcomes of incidental prostate cancer in patients who underwent radical cystectomy for bladder cancer.
Claps F; Pavan N; Umari P; Rizzo M; Barbone F; Giangreco M; Liguori G; Mir CM; Bussani R; Trombetta C
Minerva Urol Nephrol; 2021 Jun; 73(3):349-356. PubMed ID: 32026664
[TBL] [Abstract][Full Text] [Related]
22. Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign.
Li R; Metcalfe MJ; Tabayoyong WB; Guo CC; Nogueras González GM; Navai N; Grossman HB; Dinney CP; Kamat AM
Eur Urol Oncol; 2019 May; 2(3):286-293. PubMed ID: 31200843
[TBL] [Abstract][Full Text] [Related]
23. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H
Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115
[TBL] [Abstract][Full Text] [Related]
24. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
[TBL] [Abstract][Full Text] [Related]
25. Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy.
Bostrom PJ; Soloway MS; Manoharan M; Ayyathurai R; Samavedi S
J Urol; 2008 Jan; 179(1):91-5; discussion 95. PubMed ID: 17997457
[TBL] [Abstract][Full Text] [Related]
26. Implications of Definitive Prostate Cancer Therapy on Soft Tissue Margins and Survival in Patients Undergoing Radical Cystectomy for Bladder Urothelial Cancer.
Luchey AM; Lin HY; Yue B; Agarwal G; Gilbert SM; Lockhart J; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ
J Urol; 2015 Nov; 194(5):1220-5. PubMed ID: 26055823
[TBL] [Abstract][Full Text] [Related]
27. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
28. Oncologic impact of concomitant prostate cancer characteristics at the time of radical cystoprostatectomy for bladder cancer: a population-based analysis.
Kachanov M; Vetterlein MW; Soave A; Karakiewicz PI; Liakos N; Jankowski T; Pose RM; Mandrek M; Fisch M; Witt JH; Graefen M; Leyh-Bannurah SR
Aging Male; 2022 Dec; 25(1):54-61. PubMed ID: 35179092
[TBL] [Abstract][Full Text] [Related]
29. Survival outcomes following radical cystectomy in patients with prior pelvic radiation for prostate cancer: A matched cohort analysis.
Murthy PB; Lone Z; Corrigan D; Campbell R; Munoz-Lopez C; Caveney M; Gerber D; Ericson KJ; Thomas L; Zhang JH; Kaouk J; Weight C; Berglund R; Haber GP; Lee BH
Urol Oncol; 2022 Jan; 40(1):10.e13-10.e19. PubMed ID: 34400070
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer.
Onozawa M; Miyanaga N; Hinotsu S; Miyazaki J; Oikawa T; Kimura T; Takaoka E; Kawai K; Shimazui T; Sakurai H; Nishiyama H; Akaza H
Jpn J Clin Oncol; 2012 Sep; 42(9):825-30. PubMed ID: 22782963
[TBL] [Abstract][Full Text] [Related]
31. Intravesical bacillus Calmette-Guerin immunotherapy after previous prostate radiotherapy for high-grade non-muscle-invasive bladder cancer.
Rao MV; Ellimoottil C; Sondej T; Flanigan RC; Quek ML
Urol Oncol; 2013 Aug; 31(6):857-61. PubMed ID: 21868262
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer.
Sauer R; Birkenhake S; Kühn R; Wittekind C; Schrott KM; Martus P
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):121-7. PubMed ID: 9422567
[TBL] [Abstract][Full Text] [Related]
33. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
Frazier HA; Robertson JE; Dodge RK; Paulson DF
Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of palliative cystectomy in patients with locally advanced pT4 bladder cancer.
Maisch P; Lunger L; Düwel C; Schmid SC; Horn T; Gschwend JE; Sauter A; Heck MM
Urol Oncol; 2021 Jun; 39(6):368.e11-368.e17. PubMed ID: 33431328
[TBL] [Abstract][Full Text] [Related]
35. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
[TBL] [Abstract][Full Text] [Related]
36. The characteristics of bladder cancer after radiotherapy for prostate cancer.
Abern MR; Dude AM; Tsivian M; Coogan CL
Urol Oncol; 2013 Nov; 31(8):1628-34. PubMed ID: 22575239
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes of incidental prostate cancer at radical cystectomy.
Packiam VT; Tsivian M; Avulova S; Sharma V; Tarrell R; Cheville JC; Frank I; Thompson RH; Tollefson MK; Gettman MT; Karnes RJ; Thapa P; Boorjian SA
Urol Oncol; 2020 Nov; 38(11):848.e17-848.e22. PubMed ID: 32624422
[TBL] [Abstract][Full Text] [Related]
38. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
39. Initial results of retrospective study: preoperative transurethral excision plus chemotherapy and radiation therapy and trial of bladder preservation.
Gamal El-Deen HS
J Egypt Natl Canc Inst; 2007 Jun; 19(2):133-46. PubMed ID: 19034344
[TBL] [Abstract][Full Text] [Related]
40. Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy.
Reddy AV; Pariser JJ; Pearce SM; Weichselbaum RR; Smith ND; Steinberg GD; Liauw SL
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1031-9. PubMed ID: 27026309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
